Insider Selling: Dolby Laboratories (NYSE:DLB) SVP Sells $468,070.35 in Stock

Dolby Laboratories (NYSE:DLB) SVP John Couling sold 7,667 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $61.05, for a total value of $468,070.35. Following the sale, the senior vice president directly owned 118,727 shares in the company, valued at approximately $7,248,283.35. This trade represents a 6.07% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Dolby Laboratories Trading Down 0.2%

Shares of NYSE:DLB opened at $61.81 on Friday. Dolby Laboratories has a 12-month low of $48.26 and a 12-month high of $73.78. The company has a market capitalization of $5.79 billion, a PE ratio of 26.30 and a beta of 0.80. The business has a 50 day moving average of $56.58 and a two-hundred day moving average of $58.33.

Dolby Laboratories (NYSE:DLB) last issued its quarterly earnings data on Thursday, July 30th. The electronics maker reported $0.69 EPS for the quarter, topping analysts’ consensus estimates of $0.67 by $0.02. Dolby Laboratories had a net margin of 16.70% and a return on equity of 11.08%. The business had revenue of $305.00 million for the quarter, compared to analysts’ expectations of $311.96 million. During the same quarter last year, the company earned $0.78 EPS. The business’s revenue was down 3.3% on a year-over-year basis. Dolby Laboratories has set its FY 2026 guidance at 4.250-4.400 EPS and its Q4 2026 guidance at 1.130-1.280 EPS. Equities research analysts predict that Dolby Laboratories will post 3.23 earnings per share for the current fiscal year.

Dolby Laboratories Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Wednesday, August 19th. Shareholders of record on Tuesday, August 11th were issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 2.3%. The ex-dividend date of this dividend was Tuesday, August 11th. Dolby Laboratories’s dividend payout ratio (DPR) is presently 61.28%.

Dolby Laboratories announced that its Board of Directors has approved a stock repurchase plan on Thursday, July 30th that allows the company to repurchase $350.00 million in outstanding shares. This repurchase authorization allows the electronics maker to repurchase up to 7% of its shares through open market purchases. Shares repurchase plans are usually an indication that the company’s management believes its shares are undervalued.

Analyst Upgrades and Downgrades

DLB has been the topic of several research reports. Rosenblatt Securities restated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research report on Friday, August 28th. Wall Street Zen cut Dolby Laboratories from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Weiss Ratings lowered Dolby Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Thursday, August 13th. Finally, Barrington Research restated an “outperform” rating and set a $90.00 price objective on shares of Dolby Laboratories in a research report on Monday, June 15th. Two investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the company. According to data from MarketBeat, Dolby Laboratories has an average rating of “Hold” and a consensus price target of $87.50.

Hedge Funds Weigh In On Dolby Laboratories

Institutional investors have recently modified their holdings of the business. Corient Private Wealth LP purchased a new position in Dolby Laboratories in the second quarter valued at $234,000. VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new stake in Dolby Laboratories during the 2nd quarter worth about $216,000. California State Teachers Retirement System increased its holdings in Dolby Laboratories by 5,009.3% during the 2nd quarter. California State Teachers Retirement System now owns 3,705,155 shares of the electronics maker’s stock worth $194,817,000 after purchasing an additional 3,632,637 shares during the period. Ameritas Advisory Services LLC raised its position in Dolby Laboratories by 46.6% in the 2nd quarter. Ameritas Advisory Services LLC now owns 5,701 shares of the electronics maker’s stock valued at $300,000 after purchasing an additional 1,813 shares in the last quarter. Finally, AlphaGrep UK Ltd acquired a new stake in Dolby Laboratories in the 2nd quarter valued at about $649,000. Institutional investors and hedge funds own 58.56% of the company’s stock.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.